We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
AVE5026, a new hemisynthetic ultra-low-molecular-weight heparin for the prevention of venous thromboembolism in patients after total knee replacement surgery--TREK: a dose-ranging study.
- Authors
Lassen, M R; Dahl, O E; Mismetti, P; Destrée, D; Turpie, A G G
- Abstract
AVE5026 is a new hemisynthetic ultra-low-molecular-weight heparin, with a novel anti-thrombotic profile resulting from high anti-factor (F)Xa activity and residual anti-FIIa activity. AVE5026 is in clinical development for venous thromboembolism (VTE) prevention, a frequent complication after total knee replacement (TKR) surgery.
- Publication
Journal of thrombosis and haemostasis : JTH, 2009, Vol 7, Issue 4, p566
- ISSN
1538-7836
- Publication type
Journal Article
- DOI
10.1111/j.1538-7836.2009.03301.x